Stay updated on Immunotherapy Plus Radiation for Merkel Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Plus Radiation for Merkel Cell Carcinoma Clinical Trial page.

Latest updates to the Immunotherapy Plus Radiation for Merkel Cell Carcinoma Clinical Trial page
- CheckyesterdayChange DetectedA banner announces an NIH transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs. The study record itself still displays a 403 error.SummaryDifference1%

- Check8 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check15 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now shows a 403 Forbidden error with a basic header/footer, replacing the previous detailed study content and links. This means the study record content is no longer accessible at this URL.SummaryDifference17%

- Check57 days agoChange DetectedA new safety outcome, 'Number of Participants With Grade 3+ Adverse Events,' was added to the study's outcomes, and the previous endpoint 'Incidence of Adverse Events' was removed, reflecting an update to how adverse events are reported in the study record.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5, marking the current version of the study record. This change is a metadata update and does not modify the study details presented on the page.SummaryDifference0.0%

Stay in the know with updates to Immunotherapy Plus Radiation for Merkel Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Plus Radiation for Merkel Cell Carcinoma Clinical Trial page.